135 related articles for article (PubMed ID: 28126968)
1. CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2/p27
Zhang F; Liu X; Chen C; Zhu J; Yu Z; Xie J; Xie L; Bai H; Zhang Y; Fang X; Gu H; Wang C; Weng W; Zhang CC; Chen GQ; Liang A; Zheng J
Haematologica; 2017 Apr; 102(4):707-718. PubMed ID: 28126968
[TBL] [Abstract][Full Text] [Related]
2. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphatase SHP-2 is a regulator of p27(Kip1) tyrosine phosphorylation.
Tossidou I; Dangers M; Koch A; Brandt DT; Schiffer M; Kardinal C
Cell Cycle; 2008 Dec; 7(24):3858-68. PubMed ID: 19066472
[TBL] [Abstract][Full Text] [Related]
4. CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling.
Fang X; Chen C; Xia F; Yu Z; Zhang Y; Zhang F; Gu H; Wan J; Zhang X; Weng W; Zhang CC; Chen GQ; Liang A; Xie L; Zheng J
J Hematol Oncol; 2016 Nov; 9(1):124. PubMed ID: 27855694
[TBL] [Abstract][Full Text] [Related]
5. Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes.
Moros A; Bustany S; Cahu J; Saborit-Villarroya I; Martínez A; Colomer D; Sola B; Roué G
Clin Cancer Res; 2014 Jan; 20(2):393-403. PubMed ID: 24178620
[TBL] [Abstract][Full Text] [Related]
6. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.
Zhang Y; Xia F; Liu X; Yu Z; Xie L; Liu L; Chen C; Jiang H; Hao X; He X; Zhang F; Gu H; Zhu J; Bai H; Zhang CC; Chen GQ; Zheng J
J Clin Invest; 2018 May; 128(5):1737-1751. PubMed ID: 29584620
[TBL] [Abstract][Full Text] [Related]
7. SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis.
Sugimoto A; Kataoka TR; Ueshima C; Takei Y; Kitamura K; Hirata M; Nomura T; Haga H
Exp Dermatol; 2018 Jun; 27(6):641-646. PubMed ID: 29498772
[TBL] [Abstract][Full Text] [Related]
8. miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential.
Meyer SE; Muench DE; Rogers AM; Newkold TJ; Orr E; O'Brien E; Perentesis JP; Doench JG; Lal A; Morris PJ; Thomas CJ; Lieberman J; McGlinn E; Aronow BJ; Salomonis N; Grimes HL
J Exp Med; 2018 Aug; 215(8):2115-2136. PubMed ID: 29997117
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
[TBL] [Abstract][Full Text] [Related]
10. PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.
Naudin C; Hattabi A; Michelet F; Miri-Nezhad A; Benyoucef A; Pflumio F; Guillonneau F; Fichelson S; Vigon I; Dusanter-Fourt I; Lauret E
Blood; 2017 May; 129(18):2493-2506. PubMed ID: 28232582
[TBL] [Abstract][Full Text] [Related]
11. Role of SHP2 in hematopoiesis and leukemogenesis.
Pandey R; Saxena M; Kapur R
Curr Opin Hematol; 2017 Jul; 24(4):307-313. PubMed ID: 28306669
[TBL] [Abstract][Full Text] [Related]
12. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
Wang S; Raven JF; Koromilas AE
Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
[TBL] [Abstract][Full Text] [Related]
13. Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.
Weidemann RR; Behrendt R; Schoedel KB; Müller W; Roers A; Gerbaulet A
Exp Hematol; 2017 Jan; 45():45-55.e6. PubMed ID: 27664314
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection.
Wang Y; Zhong H; Xie X; Chen CY; Huang D; Shen L; Zhang H; Chen ZW; Zeng G
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3883-92. PubMed ID: 26150504
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model.
Danis E; Yamauchi T; Echanique K; Haladyna J; Kalkur R; Riedel S; Zhu N; Xie H; Bernt KM; Orkin SH; Armstrong SA; Neff T
Exp Hematol; 2015 Nov; 43(11):930-935.e6. PubMed ID: 26118502
[TBL] [Abstract][Full Text] [Related]
16. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of p27kip1 promotes chemical hepatocarcinogenesis through enhancing inflammatory cytokine secretion and STAT3 signaling activation.
Guo J; Ma Q; Zhou X; Fan P; Shan T; Miao D
J Cell Physiol; 2013 Oct; 228(10):1967-76. PubMed ID: 23460367
[TBL] [Abstract][Full Text] [Related]
18. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
Muntean AG; Hess JL
Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells.
Mitsumori T; Nozaki Y; Kawashima I; Yamamoto T; Shobu Y; Nakajima K; Morishita S; Komatsu N; Kirito K
Exp Hematol; 2014 Sep; 42(9):783-92.e1. PubMed ID: 24860972
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells.
Scholl S; Kirsch C; Böhmer FD; Klinger R
J Cancer Res Clin Oncol; 2004 Dec; 130(12):711-8. PubMed ID: 15340843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
